摘要 |
<p>The present invention relates to pyrimidine-2,4,6-trione metalloproteinase inhibitors of the formula (I) wherein X, Y, A, B and R1 are as defined in the specification, and to pharmaceutical compositions and methods of treating inflammation, cancer and other disorders.</p> |